FibroGen
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$235.30M N/A	$140.73M -40.19%	$147.75M 4.98%	Avg: $152.44M Low: $152.44M High: $152.44M avg. 3.17%	Avg: $179.63M Low: $179.63M High: $179.63M avg. 17.83%	Avg: $212.97M Low: $212.97M High: $212.97M avg. 18.56%
Net Income % change YoY	$-291.03M N/A	$-295.22M -1.44%	$-284.23M 3.72%	Avg: $-55.78M Low: $-55.78M High: $-55.78M avg. 80.37%	Avg: $-17.77M Low: $-17.77M High: $-17.77M avg. 68.13%	Avg: $106.05M Low: $106.05M High: $106.05M avg. 696.55%
EBITDA % change YoY	$-288.53M N/A	$-282.82M 1.97%	$-261.40M 7.57%	Avg: $-130.71M Low: $-130.71M High: $-130.71M avg. 49.99%	Avg: $-154.03M Low: $-154.03M High: $-154.03M avg. -17.83%	Avg: $-182.62M Low: $-182.62M High: $-182.62M avg. -18.56%
EPS % change YoY	-$3.15 N/A	-$3.15 0%	-$2.92 7.30%	Avg: -$0.57 Low: -$0.57 High: -$0.57 avg. 80.36%	Avg: -$0.18 Low: -$0.18 High: -$0.18 avg. 68.13%	Avg: $1.09 Low: $1.09 High: $1.09 avg. 696.55%
Operating Expenses % change YoY	$510.96M N/A	$421.47M -17.51%	$398.11M -5.54%	Avg: $101.34M Low: $101.34M High: $101.34M avg. -74.54%	Avg: $119.42M Low: $119.42M High: $119.42M avg. 17.83%	Avg: $141.59M Low: $141.59M High: $141.59M avg. 18.56%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 281.68% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is -55.78M, average is -55.78M and high is -55.78M.

Wall Street analysts forecast annual average revenue growth of 13.19% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $152.44M, average is $152.44M and high is $152.44M.

Wall Street analysts forecast annual average earnings growth of 281.68% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.57, average is -$0.57 and high is $-0.57.